# Santa Maria Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/santa-maria-biotherapeutics

- Industry: Healthcare Specialists
- Headquarters: Brisbane, US
- Total disclosed funding: $18M
- Latest round: Series B (Dec 3, 2013)
- Investors on record: 7

## About

Founded in 2012 and based in California, US, Santa Maria Biotherapeutics, Inc. engages in the development of therapies for the mitigation of cachexia in the treatment of ovarian cancer.

## Funding rounds

- Series B, Dec 3, 2013, $18M — Domain Associates, Kleiner Perkins, DAG Ventures, Alexandria Venture Investments, Amgen Ventures, EcoR1 Capital, Bristol-Myers Squibb Company

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B
- EcoR1 Capital (https://capitalatlas.ai/funds/ecor1-capital) — Series B
- Bristol-Myers Squibb Company — Series B